Aerie Pharmaceuticals reported $351.8M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Adamas Pharmaceuticals ADMS:US 143.98M 6.67M
Aerie Pharmaceuticals AERI:US $ 351.8M 3.73M
Alimera Sciences ALIM:US $ 60.06M 2.04M
Amarin AMRN:US $ 1035.8M 9.19M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Cara Therapeutics CARA:US $ 225.09M 3.64M
Coherus Biosciences CHRS:US $ 741.73M 2.18M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
Insmed INSM:US $ 1.31B 81.99M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Novartis NOVN:VX SF 121209M 2806M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Supernus Pharmaceuticals SUPN:US $ 1555.04M 18.02M
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M
Valeant Pharmaceuticals VRX:CN $ 29252M 790M
Zoetis ZTS:US $ 13705M 364M
Zogenix ZGNX:US $ 496.99M 43.09M